Most of us know that medicines carry risks as well as rewards, but just how are they monitored?

‍

‍

This presentation by the European Medicines Agency does a fantastic job of explaining, in a straightforward way, how the safety of new covid19 drugs are monitored and recorded throughout each step of the drugdevelopment process.

—

Providing a full suite of pharmaceutical services for over two decades, QUINTA-ANALYTICA are market-leaders in drug testing, clinical studies, bioanalytical services & more.

Get in toush with us today to discuss how we can help support you.

‍

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

ALL POSTS